Related references
Note: Only part of the references are listed.In vitro effect of anti-human immunodeficiency virus CCR5 antagonist maraviroc on chemotactic activity of monocytes, macrophages and dendritic cells
R. Rossi et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART
Marta Massanella et al.
AIDS (2010)
Nadir CD4 T Cell Count as Predictor and High CD4 T Cell Intrinsic Apoptosis as Final Mechanism of Poor CD4 T Cell Recovery in Virologically Suppressed HIV-Infected Patients: Clinical Implications
Eugenia Negredo et al.
CLINICAL INFECTIOUS DISEASES (2010)
The Relationship of CCR5 Antagonists to CD4+T-Cell Gain: A Meta-Regression of Recent Clinical Trials in Treatment-Experienced HIV-Infected Patients
Timothy J. Wilkin et al.
HIV CLINICAL TRIALS (2010)
Maraviroc versus Efavirenz, Both in Combination with Zidovudine-Lamivudine, for the Treatment of Antiretroviral-Naive Subjects with CCR5-Tropic HIV-1 Infection
David A. Cooper et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
The design and validation of a novel phenotypic assay to determine HIV-1 coreceptor usage of clinical isolates
Nina H. Lin et al.
JOURNAL OF VIROLOGICAL METHODS (2010)
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μL in Europe and North America: a pooled cohort observational study
Rebecca K. Lodwick et al.
LANCET (2010)
Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy
Benoit Marin et al.
AIDS (2009)
Incidence of Non-AIDS-Defining Malignancies in HIV-Infected Versus Noninfected Patients in the HAART Era: Impact of Immunosuppression
Roger J. Bedimo et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
CCR5 Expression Levels Influence NFAT Translocation, IL-2 Production, and Subsequent Signaling Events during T Lymphocyte Activation
Jose F. Camargo et al.
JOURNAL OF IMMUNOLOGY (2009)
Interleukin-2 Therapy in Patients with HIV Infection
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals
Jessica L. Long et al.
AIDS (2008)
Treatment initiation with zidovudine-containing potent antiretroviral therapy impairs CD4 cell count recovery but not clinical efficacy
Angela C. Huttner et al.
AIDS (2007)
An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults
John A. Bartlett et al.
AIDS (2006)
Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City
Judith E. Sackoff et al.
ANNALS OF INTERNAL MEDICINE (2006)
Liver-related deaths in persons infected with the human immunodeficiency virus -: The D:A:D study
Rainer Weber
ARCHIVES OF INTERNAL MEDICINE (2006)
Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: Results from ACTG 384
Rajesh T. Gandhi et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy:: Association of immune activation, T cell maturation markers, and cellular HIV-1 DNA
Miguel Goicoechea et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4 T cell-dendritic cell interaction
F Castellino et al.
NATURE (2006)
Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis
Isabel J. Crane et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads
O Benveniste et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load
E Negredo et al.
AIDS (2004)
Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count
F García et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
Immunophenotypic markers and antiretroviral therapy (IMART): T cell activation and maturation help predict treatment response
D Mildvan et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Combination antiretroviral therapy and the risk of myocardial infarction
N Friis-Moller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function
L Teixeira et al.
AIDS (2001)
Share Paper
